MedTrace Logo

Symptoms and Endoscopic Results in Consideration of Pretreatment

NCT00612404 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 16255

Last updated 2008-02-11

No results posted yet for this study

Summary

Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose, duration, etc.), routine assessments, the participating physicians (i.e. gastroenterologists) are asked to document relevant data in patients with gastrointestinal disorders.

Conditions

  • Gastrointestinal Diseases

Sponsors & Collaborators

Principal Investigators

  • Kai Richter, MD · Medical Department AstraZeneca Germany

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-09-30
Primary Completion
2005-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00612404 on ClinicalTrials.gov